Anti-microbial Effect and in Vivo Ocular Delivery of Ciprofloxacin-loaded Liposome through Rabbit’s Eye

References

• Taha EI, El-Anazi MH, El-Bagory IM, Bayomi MA. Design of liposomal colloidal systems for ocular delivery of ciprofloxacin. Saudi Pharm J. 2014 Jul 01;22(3):231–39. doi:10.1016/j.jsps.2013.07.003.
   PubMed Web of Science ®Google Scholar
• Lumi XPG, Vasileva B, Thaler A. Endophthalmitis prevention, diagnostic procedures and treatment. Optom Open Access. 2016;1(2):108. doi:10.4172/2476-2075.1000108.
   Google Scholar
• Barry P, Seal DV, Gettinby G, Lees F, Peterson M, Revie CW. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: preliminary report of principal results from a European multicenter study. J Cataract Refract Sur. 2006;32(3):407–10. doi:10.1016/j.jcrs.2006.02.021.
   PubMed Web of Science ®Google Scholar
• Durand ML. Endophthalmitis. Clin Microbiol Infect. 2013;19(3):227–34. doi:10.1111/1469-0691.12118.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Iezhitsa I, Agarwal P, Abdul Nasir NA, Razali N, Alyautdin R, Mohd Ismail N. Liposomes in topical ophthalmic drug delivery: an update. Drug Del. 2016 May;23(4):1075–91.
   PubMed Web of Science ®Google Scholar
• Emmett T, Cunningham PR. General ophthalmology. 18 th ed. New York (NY): McGraw Hill Professional; 2012.
   Google Scholar
• Wilhelmus KR, Hyndiuk RA, Caldwell DR, Abshire RL, Folkens AT, Godio LB. 0.3% ciprofloxacin ophthalmic ointment in the treatment of bacterial keratitis. Arch Ophthal. 1993;111(9):1210–18. doi:10.1001/archopht.1993.01090090062020.
   PubMedGoogle Scholar
• Fisher LM, Lawrence JM, Josty IC, Hopewell R, Margerrison EEC, Cullen ME. Ciprofloxacin and the fluoroquinolones: new concepts on the mechanism of action and resistance. Am J Med. 1989;87(5):S2–S8. doi:10.1016/0002-9343(89)90010-7.
   PubMed Web of Science ®Google Scholar
• Ross DL, Riley CM. Aqueous solubilities of some variously substituted quinolone antimicrobials. Int J Pharm. 1990;63:237–50. doi:10.1016/0378-5173(90)90130-V.
   Web of Science ®Google Scholar
• Wilhelmus KR, Abshire RL. Corneal ciprofloxacin precipitation during bacterial keratitis. Am Ophtalmol. 2003;136:1032–37. doi:10.1016/S0002-9394(03)00636-6.
   PubMed Web of Science ®Google Scholar
• Morlet N, Graham GC, Gatus B, McLachlan AJ, Slonikas C, Naidoo D, Goldberg I, Lam CM. Pharmacokinetics of ciprofloxacin in the human eye: a clinical study and population pharmacokinetic analysis. Antimicrob Agent Chemother. 2000;44(6):1674–79. doi:10.1128/AAC.44.6.1674-1679.2000.
   PubMed Web of Science ®Google Scholar
• Cekic O, Batman C, Yasar U, Basic NE, Bozkurt A, Kayaalp SO. Human aqueous and vitreous humor levels of ciprofloxacin after oral and topical administration. Eye. 1999;13:555–58. doi:10.1038/eye.1999.137.
   PubMed Web of Science ®Google Scholar
• Hariprasad SM, Blinder KJ, Shah GK, Apte RS, Rosenblatt B, Holekamp NM, Thomas MA, Mieler WF, Chi J, Prince RA. Penetration pharmacokinetics of topically administrated 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreeous. Arch Ophthalmic. 2005;123:39–44. doi:10.1001/archopht.123.1.39.
   PubMed Web of Science ®Google Scholar
• Lee VHL, Carson LW. Ocular disposition of inulin from single & multiple doses of positively charged multilamellar liposomes: evidence for alterations in tear dynamics and ocular surface characteristics. J Ocular Pharmacol Therapeut. 1986;2(4):353–64. doi:10.1089/jop.1986.2.353.
   Google Scholar
• Mishra GP, Bagui M, Tamboli V, Mitra AK. Recent application of liposome in ophthalmic drug delivery. J Drug Del. 2011. Article ID: 863734. 1155/2011/863734.
   PubMedGoogle Scholar
• Patel A, Cholkar K, Agrahari V, Mitra AK. Ocular drug delivery systems: an overview. World J Pharmacol. 2013;2(2):47–64. doi:10.5497/wjp.v2.i2.47.
   PubMedGoogle Scholar
• Pleyer U, Lutz S, Jusko WJ, Nguyen KD, Narawane M, Ruckert D, Mondino BJ, Lee VH, Nguyen K. Ocular absorption of topically applied FK506 from liposomal and oil formulations in the rabbit eye. Invest Ophthalmol & Visual Sci. 1993 Aug;34(9):2737–42.
   PubMed Web of Science ®Google Scholar
• Duzgune S, Nir S. Mechanisms and kinetics of liposome-cell interactions. Adv Drug Del Rev. 1999 Nov 10;40(1–2):3–18. doi:10.1016/S0169-409X(99)00037-X.
   PubMed Web of Science ®Google Scholar
• Allen TM, McAllister L, Mausolf S, Gyorffy E. Liposome-cell interactions. A study of the interactions of liposomes containing entrapped anti-cancer drugs with the EMT6, S49 and AE1 (transport-deficient) cell lines. Biochim Et Biophys Acta. 1981 May 6;643(2):346–62. doi:10.1016/0005-2736(81)90080-8.
   PubMed Web of Science ®Google Scholar
• Yadav DSK, Pandey D, Dutta RK. Liposomes for drug delivery. J Biotechnol Biomater. 2017;7:276. doi:10.4172/2155-952X.1000276.
   Google Scholar
• Hosny KM. Ciprofloxacin as ocular liposomal hydrogel. AAPS PharmSciTech. 2010;11(1):241–46. doi:10.1208/s12249-009-9373-4.
   PubMed Web of Science ®Google Scholar
• Karn PR, Vanic Z, Pepic I, Skalko-Basnet N. Mucoadhesive liposomal delivery system: the choice of coating material. Drug Devel Indust Pharm. 2011;37:382–88.
   Web of Science ®Google Scholar
• Gilhotra RM, Nagpal K, Mishra DN. Azithromycin novel drug delivery system for ocular application. Int J Pharm Invest. 2011;1(1):22–28. doi:10.4103/2230-973X.76725.
   PubMedGoogle Scholar
• Singh S, Vardham H, Kotla NG, Maddiboyina B, Sharma D, Webster TJ. the role of surfactants in the formulation of elastic liposomal gels containing a synthetic opioid analgesic. Int J Nanomed. 2016;11:1475–82.
   PubMed Web of Science ®Google Scholar
• Callegan MC, Engelbert M, Parke DW, Jett BD, Gilmore MS. Bacterial endophthalmitis: epidemiology, therapeutics and bacterium-host interaction. Clin Microbial Rev. 2002;15(1):111–24. doi:10.1128/CMR.15.1.111-124.2002.
   PubMed Web of Science ®Google Scholar
• Nussenblatt RBA, Palestine CC, Roberge F. Standardation of vitreal inflammation activity in intermediate and posterior uveitis. Ophthalmol. 1985;98:467–71. doi:10.1016/S0161-6420(85)34001-0.
   Google Scholar
• Tai-Lee K, Gerald C, Barry S, Matter LJ. Ocular bioavailability of ciprofloxacin in sustained release formulations. J Ocular Pharmacol Therapeut. 2001;17(6):555–63. doi:10.1089/10807680152729248.
   PubMed Web of Science ®Google Scholar
• Jain RL, Shastri JP. Study of ocular drug delivery system using drug-loaded liposomes. Int J Pharm Invest. 2011;1(1):35–41. doi:10.4103/2230-973X.76727.
   PubMedGoogle Scholar
• Zhang R, Qian J, Guo J, Xue K, Yaun YF. Treatment of experimental autoimmune uveoretinitis with intravitreal injection of tacrolimus encapsulated in liposomes. Invest Ophthalmol Visual Sci. 2010;51(7):3575–82. doi:10.1167/iovs.09-4373.
   PubMed Web of Science ®Google Scholar
• Danion A, Arsenault I, Vermette P. Antibacterial activity contact lenses bearing surface-immobolized layers of intact liposomes loaded with levofloxacin. J Pharm Sci. 2007;96(9):2350–63. doi:10.1002/jps.20871.
   PubMed Web of Science ®Google Scholar
• Afouna MI, Khattab IS, Reddy IK. Preparation and characterization of demeclocycline liposomal formulations and assessment of their intraocular pressure-lowering effects. Cutaneous Ocul Toxicol. 2005;24(2):111–24. doi:10.1081/CUS-200059582.
   PubMed Web of Science ®Google Scholar
• Abdelbary G. Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes. Pharm Devel Tech. 2009;16(1):44–56. doi:10.3109/10837450903479988.
   PubMed Web of Science ®Google Scholar
• Taha EI, Badran MM, El-Anazi M, Bayomi MA, El-Bagory IM. Role of pluronic F127 micelles in enhancing ocular delivery of ciprofloxacin. J Mol Liq. 2014;199:251–56. doi:10.1016/j.molliq.2014.09.021.
   Web of Science ®Google Scholar
• Garbwal R, Shady SF, Ellis EJ, Ellis JY, Leahy CD, McCarthy SP, Crawford KS, Gaines P. Sustained ocular delivery of CPX using nanospheres and conventional contact lens. Invest Ophthal Visual Sci. 2012;53:1341–52. doi:10.1167/iovs.11-8215.
   PubMed Web of Science ®Google Scholar
• Ke TL, Cagle G, Schlech B, Lorenzetti OJ, Mattern J. Ocular Pharmacol Therapeut. 2004;17(6). doi:10.1089/108.7680152729248.
   Google Scholar